Secura Bio
Secura Bio, Inc.
1995 Village Center Circle, Suite 128
Las Vegas, NV 89134
Phone: (858) 251-1414Website: https://securabio.com/Careers: securabio.com/careersPatient Assistance Program: securabio.com/patient-support-programs
Latest news
- Secura Bio Announces Copiktra (duvelisib) Strategic Focus On T-cell Lymphoma And Voluntary U.S. Withdrawal Of The Relapsed Or Refractory Follicular Lymphoma Indication
3 December 2021 - Secura Bio Announces U.S. Withdrawal of Farydak (panobinostat) NDA
30 November 2021 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
24 September 2018 - FDA Accepts New Drug Application for Duvelisib and Grants Priority Review
9 April 2018 - Verastem Submits NDA to FDA for Duvelisib for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
7 February 2018 - Verastem Announces Regulatory Strategy for Duvelisib New Drug Application Following Guidance from FDA
31 October 2017 - Verastem Expands Duvelisib Development Program to Include Peripheral T-Cell Lymphoma
6 September 2017 - FDA Approves Farydak (panobinostat) for Multiple Myeloma
23 February 2015 - Novartis Announces Outcome of FDA Advisory Committee Meeting for LBH589 (Panobinostat)
6 November 2014
Drugs Associated with Secura Bio, Inc.
Secura Bio, Inc. manufactures, markets and/or distributes more than 1 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Copiktra
Generic name: duvelisib Drug class: PI3K inhibitors |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Farydak
Generic name: panobinostat Drug class: histone deacetylase inhibitors |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
